Based on 3 analysts giving stock ratings to Mesoblast Ltd in the past month.
Buy
0 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
36.500USD+155.42%
MESO Analyst Recommendation Trends
In the current month, MESO has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MESO average Analyst price target in the last month is 36.500.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
Strong Buy
0
0
0
0
0
0
0
0
Buy
3
3
3
3
3
3
3
3
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
3
3
3
3
3
3
3
3
MESO Analyst Rating for Peer Comparison
Updated: Oct 11, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
14
1
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
11
3
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Biontech SE
BNTX
4
13
5
0
0
22
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026
Forecast
--
Actual
-0.44
Surprise
--
FAQs
What is Mesoblast Ltd's price target?
Analysts forecast that Mesoblast Ltd's price target is USD 36.50, with the highest forecast at USD 39.00 and the lowest forecast at USD 34.00.
What is the analyst rating for Mesoblast Ltd?
Based on the ratings of Mesoblast Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.